Targeting inflammatory signaling pathways with SGLT2 inhibitors: Insights into cardiovascular health and cardiac cell improvement
Fatmah R. Alsereidi(Mayo Clinic), Mohamed A. Saleh, Ahmed M. Al-Rawi(University of Sharjah), Hezlin Marzook(University of Sharjah), Anamika Gupta(University of Sharjah), Zenith Khashim(Mayo Clinic in Florida), Mahmoud M. Ramadan(Mansoura University)
Cited by 40
Related Papers
Targeting Hypoxia-Inducible Factor-1 (HIF-1) in Cancer: Emerging Therapeutic Strategies and Pathway Regulation
|Pharmaceuticals|2024|101
Ligand-Based Design on the Dog-Bone-Shaped BIBR1532 Pharmacophoric Features and Synthesis of Novel Analogues as Promising Telomerase Inhibitors with In Vitro and In Vivo Evaluations
|Journal of Medicinal Chemistry|2022|66
Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and/or anti-SARS-CoV-2
|Life Sciences|2022|62